More patients are being prescribed ADHD medication by GPs in our region, new figures show.

The uptick in prescribing comes amid a shortage of key drugs used to treat the condition.

Attention deficit hyperactivity disorder is a condition where adults and children may have difficulty concentrating, act impulsively and appear restless.

Figures from the NHS Open Prescribing service show 8,226 patients received ADHD medication in the former NHS Buckinghamshire, Oxfordshire and Berkshire West integrated care board area in the three months to June.

READ MORE: Drink driver admitted guilt from sick bed, court told

This was a rise from 6,532 patients during the same period last year, and a jump of 99 from 4,131 in the spring of 2020.

These figures cover how many patients with an NHS number picked up a prescription during that time frame – accounting for 87 per cent of prescriptions received in the area. In 2020 this covered 90 per cent of prescriptions.

The ADHD Foundation said just over 200,000 (10 per cent) of an estimated 2 million UK citizens with the condition are receiving medication.

Tony Lloyd, CEO of the charity, said ADHD has been significantly underdiagnosed – particularly among women. He attributes the increase in prescribing to "rebalancing" this underdiagnosis.

However, he added: "Medication should not be used in isolation and should form part of a range of strategies and lifestyle choices to manage ADHD successfully."

In September, the NHS issued a national patient safety alert about a shortage of certain drugs used to treat the condition. The shortages are expected to be resolved between October and December.

These include some formats of the most prescribed drug for ADHD – methylphenidate hydrochloride – alongside all lisdexamfetamine and guanfacine medication. The NHS has previous said there is also a shortage of some types of atomoxetine.

In Buckinghamshire, Oxfordshire and Berkshire, 7,603 patients were prescribed one of these drugs in some form in the three months to June.

Henry Shelford, CEO of the ADHD UK charity, said medication is "life-changing" for those with the condition – and taking it away can have disastrous consequences.

READ MORE: Three people rescued from floodwater on Oxfordshire road

He said: "The NHS should have realised that this was happening and had a plan in place. Instead, people are only finding out when their pharmacy can't supply. They've been left stranded with no support."

A spokesperson for the Department of Health and Social Care said: "We are aware of supply issues affecting medicines used for the management of ADHD due to increased global demand, and we have issued communications to the NHS to advise healthcare professionals on management of patients during this time.

"We continue to work closely with the respective manufacturers to resolve the issues as soon as possible and to ensure patients have continuous access to ADHD medicines in the UK."